Germany
Japan
United Kingdom
China
Fluorescent Protein Antibodies
MME/CD10 mouse monoclonal antibody, clone UMAB235
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
MME/CD10 mouse monoclonal antibody, clone UMAB236
| Applications | 10k-ChIP, FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Category
-
- Antibodies
-
-
-
-
-
Filter by
Target Symbol
- CD68 (132)
- PTPRC (117)
- CD44 (111)
- CD19 (92)
- KIT (89)
- CD33 (88)
- NCAM1 (78)
- CD163 (70)
- CD34 (69)
- FCGR2A (64)
- CD22 (62)
- CD38 (61)
- CD3E (56)
- MME (47)
- IL3RA (31)
- FCGR3A (29)
- ITGB3 (28)
- ITGAM (23)
- CD7 (21)
- FLT3 (17)
- ITGA4 (16)
- CD55 (15)
- CD247 (14)
- ITGA2B (14)
- FCGR2B (13)
- ITGA3 (13)
- ITGB2 (12)
- ITGA5 (11)
- ITGAX (10)
- ITGA6 (9)
- KLRD1 (9)
- CCR3 (8)
- LTBR (8)
- CD3EAP (6)
- ITGA2 (6)
- THY1 (6)
- CD3D (5)
- IL5RA (5)
- SIGLEC6 (5)
- CD3G (4)
- GP1BA (4)
- GYPA (4)
- ITGA1 (4)
- SIGLEC15 (4)
- SIGLEC5 (3)
- CD16 (2)
- CD16 (FCGR3A) (2)
- FCGR2C (2)
- FCGR3B (2)
- ITGB7 (2)
- MMP12 (2)
- CALD1 (1)
- CD10 (1)
- CD163L1 (1)
- FCGR2 (1)
- FCGR3A3 (1)
- FLJ22814 (1)
- GP9 (1)
- PTPRCAP (1)
- TARP (1)
Reactivities
Applications
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
- Unmodified (45)
- Phospho-specific (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (4)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- Phospho Y589/591 (1)
- Phospho Y719 (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (1)
- This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Transmembrane (1207)
- Druggable Genome (1089)
- ES Cell Differentiation/IPS (624)
- Adult stem cells (244)
- Embryonic stem cells (244)
- Cancer stem cells (191)
- Phosphatase (106)
- Stem cell relevant signaling - DSL/Notch pathway (99)
- Protein Kinase (95)
- Secreted Protein (94)
- Stem cell - Pluripotency (84)
- Protease (44)
- Induced pluripotent stem cells (31)
- GPCR (4)
- Transcription Factors (2)
Pathways
- Hematopoietic cell lineage (708)
- Cell adhesion molecules (CAMs) (331)
- Primary immunodeficiency (222)
- Fc gamma R-mediated phagocytosis (200)
- ECM-receptor interaction (158)
- T cell receptor signaling pathway (147)
- B cell receptor signaling pathway (143)
- Cytokine-cytokine receptor interaction (131)
- Lysosome (126)
- Pathways in cancer (116)
- Acute myeloid leukemia (95)
- Systemic lupus erythematosus (95)
- Regulation of actin cytoskeleton (86)
- Endocytosis (84)
- Melanogenesis (84)
- Prion diseases (72)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (55)
- Dilated cardiomyopathy (55)
- Focal adhesion (55)
- Hypertrophic cardiomyopathy (HCM) (55)
- Natural killer cell mediated cytotoxicity (45)
- Alzheimer's disease (42)
- Renin-angiotensin system (42)
- Leukocyte transendothelial migration (33)
- Calcium signaling pathway (31)
- Metabolic pathways (31)
- Nicotinate and nicotinamide metabolism (31)
- Jak-STAT signaling pathway (25)
- Apoptosis (23)
- Small cell lung cancer (21)
- Viral myocarditis (12)
- Antigen processing and presentation (7)
- Graft-versus-host disease (7)
- Complement and coagulation cascades (6)
- Chemokine signaling pathway (4)
- Vascular smooth muscle contraction (1)